Literature DB >> 27733246

Clinical implication of body size phenotype on heart rate variability.

Hye Jin Yoo1, Soon Young Hwang2, Kyung Mook Choi1, Sei Hyun Baik1, Eun Mi Lee3, Eung Joo Kim4, Seung-Woon Rha4, Chang Gyu Park4, Dong Joo Oh4, Hong Seog Seo5.   

Abstract

We compared heart rate variability (HRV) values according to the following body size phenotypes: metabolically healthy normal weight (MHNW), metabolically unhealthy but normal weight (MUNW), metabolically healthy but obese (MHO), and metabolically unhealthy obese (MUO). We retrospectively analyzed a dataset from 1200 participants who had visited the Cardiovascular Center at Korea University Guro Hospital between March 2009 and February 2014 and underwent Holter monitoring for 24h. HRV was calculated from standard deviation of normal-to-normal R-R intervals (SDNN), standard deviation of the average normal-to-normal intervals (SDANN), and root mean square of successive differences (rMSSD) measurements, and study subjects were classified according to body mass index (BMI) and presence or absence of metabolic syndrome. Various HRV indices, including SDNN, SDANN, and rMSSD, were significantly lower in MUNW subjects than in MHNW or MHO subjects, while there were no significant differences between MUNW and MUO subjects. Although BMI had no significant correlation with any HRV indices, SDNN, SDANN, and rMSSD values had significant negative correlations with waist circumference and levels of C-reactive proteins, AST, ALT, fasting glucose, and HOMA-IR. A significant positive correlation was observed between HRV index and HDL level. Furthermore, the SDNN value significantly decreased with an increase in the number of metabolic syndrome components after adjusting for other covariates. Compared to MHNW or MHO subjects, Korean men and women with the MUNW phenotype exhibited decreased HRV, suggesting that low HRV is related to adverse cardiovascular outcomes in MUNW individuals.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Body size phenotype; Cardiac autonomic dysfunction; Heart rate variability; Metabolic syndrome; Obesity

Mesh:

Year:  2016        PMID: 27733246     DOI: 10.1016/j.metabol.2016.08.002

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  5 in total

1.  Reduced heart rate variability is related to the number of metabolic syndrome components and manifest diabetes in the sixth Tromsø study 2007-2008.

Authors:  Naomi Azulay; Roy Bjørkholt Olsen; Christopher Sivert Nielsen; Audun Stubhaug; Trond Geir Jenssen; Henrik Schirmer; Arnoldo Frigessi; Leiv Arne Rosseland; Christian Tronstad
Journal:  Sci Rep       Date:  2022-07-14       Impact factor: 4.996

2.  Changes in heart rate variability (HRV) in patients with severe and moderate obstructive sleep apnea before and after acute CPAP therapy during nocturnal polysomnography.

Authors:  Neda Efazati; Besharat Rahimi; Mahsa Mirdamadi; Maryam Edalatifard; Anahita Tavoosi
Journal:  Sleep Sci       Date:  2020 Apr-Jun

3.  Role of Type and Volume of Recreational Physical Activity on Heart Rate Variability in Men.

Authors:  Shaea Alkahtani; Andrew A Flatt; Jawad Kanas; Abdulaziz Aldyel; Syed Shahid Habib
Journal:  Int J Environ Res Public Health       Date:  2020-04-15       Impact factor: 3.390

Review 4.  Heart rate variability in type 2 diabetes mellitus: A systematic review and meta-analysis.

Authors:  Thomas Benichou; Bruno Pereira; Martial Mermillod; Igor Tauveron; Daniela Pfabigan; Salwan Maqdasy; Frédéric Dutheil
Journal:  PLoS One       Date:  2018-04-02       Impact factor: 3.240

5.  Heart rate variability based on risk stratification for type 2 diabetes mellitus.

Authors:  Julia Silva-E-Oliveira; Pâmela Marina Amélio; Isabela Lopes Laguardia Abranches; Dênis Derly Damasceno; Fabianne Furtado
Journal:  Einstein (Sao Paulo)       Date:  2017 Apr-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.